J. Marrero

690 total citations
5 papers, 548 citations indexed

About

J. Marrero is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, J. Marrero has authored 5 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Epidemiology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in J. Marrero's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (1 paper). J. Marrero is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (1 paper). J. Marrero collaborates with scholars based in United States, Spain and Japan. J. Marrero's co-authors include Alan P. Venook, Riccardo Lencioni, Masatoshi Kudo, Peter R. Galle, Michel Beaugrand, Andrea Nadel, M. Moscovici, Jordi Bruix, Ming Shan and Josep M. Llovet and has published in prestigious journals such as Hepatology, Journal of Hepatology and International Journal of Clinical Practice.

In The Last Decade

J. Marrero

5 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Marrero United States	4	466	311	137	101	68	5	548
Jinna Chu United States	5	526 1.1×	366 1.2×	135 1.0×	78 0.8×	72 1.1×	6	646
Volker Penndorf Germany	7	365 0.8×	252 0.8×	110 0.8×	54 0.5×	67 1.0×	10	514
Janine Graham United Kingdom	4	525 1.1×	433 1.4×	110 0.8×	76 0.8×	69 1.0×	5	662
Kazuhisa Kodama Japan	12	311 0.7×	212 0.7×	105 0.8×	70 0.7×	62 0.9×	34	444
Ling Han United States	5	438 0.9×	254 0.8×	163 1.2×	81 0.8×	85 1.3×	6	582
Shiro Takami Japan	6	354 0.8×	247 0.8×	104 0.8×	55 0.5×	35 0.5×	14	416
B. Mccolgan United States	10	682 1.5×	422 1.4×	266 1.9×	70 0.7×	135 2.0×	23	821
Pei‐Wu Zhu China	13	383 0.8×	172 0.6×	117 0.9×	39 0.4×	112 1.6×	34	501
Yusaku Shirai Japan	10	246 0.5×	155 0.5×	111 0.8×	35 0.3×	78 1.1×	16	406
Nwe Ni Than United Kingdom	12	455 1.0×	350 1.1×	118 0.9×	39 0.4×	115 1.7×	25	664

Countries citing papers authored by J. Marrero

Since Specialization

Citations

This map shows the geographic impact of J. Marrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Marrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Marrero more than expected).

Fields of papers citing papers by J. Marrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Marrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Marrero. The network helps show where J. Marrero may publish in the future.

Co-authorship network of co-authors of J. Marrero

This figure shows the co-authorship network connecting the top 25 collaborators of J. Marrero. A scholar is included among the top collaborators of J. Marrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Marrero. J. Marrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Tajfirouz, Deena, Ajay A. Madhavan, J. Marrero, et al.. (2024). Frequency of Asymptomatic Optic Nerve Enhancement in 203 Patients With MOG Antibody-Associated Disease. Neurology Neuroimmunology & Neuroinflammation. 11(5). e200277–e200277. 4 indexed citations

2.

Lencioni, Riccardo, et al.. (2010). Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study. International Journal of Clinical Practice. 64(8). 1034–1041. 51 indexed citations

3.

Galle, Peter R., Jean‐Frédéric Blanc, Jean‐Luc Van Laethem, et al.. (2008). 994 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND PRIOR ANTI-TUMOR THERAPY: A SUBANALYSIS FROM THE SHARP TRIAL. Journal of Hepatology. 48. S372–S372. 10 indexed citations

4.

Николаева, Ольга Викторовна, Laura Steel, Claus J. Fimmel, et al.. (2003). 1261 GP73, a resident golgi membrane protein, appears in sera of patients with viral liver disease and hepatocellular cancer. Hepatology. 38. 768–768. 3 indexed citations

5.

Marrero, J.. (2002). NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 36(6). 1349–1354. 480 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact